The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 42, Pages eabb8543
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-10-15
DOI
10.1126/sciadv.abb8543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide association study of medication-use and associated disease in the UK Biobank
- (2019) Yeda Wu et al. Nature Communications
- Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
- (2019) Phuong A. Nguyen et al. Nature Communications
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
- (2019) Pablo Garcia-Pavia et al. CIRCULATION
- A genetics-led approach defines the drug target landscape of 30 immune-related traits
- (2019) Hai Fang et al. NATURE GENETICS
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- A global overview of pleiotropy and genetic architecture in complex traits
- (2019) Kyoko Watanabe et al. NATURE GENETICS
- Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
- (2019) Emily A. King et al. PLoS Genetics
- Multi-ethnic genome-wide association study for atrial fibrillation
- (2018) Carolina Roselli et al. NATURE GENETICS
- Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study
- (2018) Christopher DeBoever et al. Nature Communications
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Genomic atlas of the human plasma proteome
- (2018) Benjamin B. Sun et al. NATURE
- Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
- (2018) Evangelos Evangelou et al. NATURE GENETICS
- Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing
- (2018) Valentina Lo Sardo et al. CELL
- An atlas of genetic associations in UK Biobank
- (2018) Oriol Canela-Xandri et al. NATURE GENETICS
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019
- (2018) Annalisa Buniello et al. NUCLEIC ACIDS RESEARCH
- Phenome-wide association studies across large population cohorts support drug target validation
- (2018) Dorothée Diogo et al. Nature Communications
- Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study
- (2018) E. A. M. (Lieke) Feijen et al. Journal of the American Heart Association
- Genetic effects on gene expression across human tissues
- (2017) François Aguet et al. NATURE
- Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk
- (2017) Helen R Warren et al. NATURE GENETICS
- Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation
- (2017) Ingrid E Christophersen et al. NATURE GENETICS
- ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
- (2017) David Lagares et al. NATURE MEDICINE
- DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
- (2017) Kelsy C Cotto et al. NUCLEIC ACIDS RESEARCH
- The druggable genome and support for target identification and validation in drug development
- (2017) Chris Finan et al. Science Translational Medicine
- Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway
- (2017) Laura La Paglia et al. PPAR Research
- Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
- (2017) Pim van der Harst et al. CIRCULATION RESEARCH
- PhenoScanner: a database of human genotype–phenotype associations
- (2016) James R. Staley et al. BIOINFORMATICS
- FINEMAP: efficient variable selection using summary data from genome-wide association studies
- (2016) Christian Benner et al. BIOINFORMATICS
- Shared Risk Factors in Cardiovascular Disease and Cancer
- (2016) Ryan J. Koene et al. CIRCULATION
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors
- (2016) Nicola Maurea et al. Journal of Cardiovascular Medicine
- Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension
- (2016) Praveen Surendran et al. NATURE GENETICS
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Database Resources of the National Center for Biotechnology Information
- (2016) NUCLEIC ACIDS RESEARCH
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- Approximately independent linkage disequilibrium blocks in human populations
- (2015) Tomaz Berisa et al. BIOINFORMATICS
- Hypertension: Renin-Angiotensin-Aldosterone System Alterations
- (2015) L. te Riet et al. CIRCULATION RESEARCH
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Opportunities for drug repositioning from phenome-wide association studies
- (2015) Majid Rastegar-Mojarad et al. NATURE BIOTECHNOLOGY
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
- (2015) Majid Nikpay et al. NATURE GENETICS
- A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
- (2015) Folefac Aminkeng et al. NATURE GENETICS
- Erratum: Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Systems biology approaches to adverse drug effects: the example of cardio-oncology
- (2015) Sherry-Ann Brown et al. Nature Reviews Clinical Oncology
- The SIDER database of drugs and side effects
- (2015) Michael Kuhn et al. NUCLEIC ACIDS RESEARCH
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- GRASP v2.0: an update on the Genome-Wide Repository of Associations between SNPs and phenotypes
- (2014) John D. Eicher et al. NUCLEIC ACIDS RESEARCH
- Regulation of lipoprotein lipase by Angptl4
- (2014) Wieneke Dijk et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis
- (2013) Zexing Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study
- (2013) Jorge Cortes et al. LANCET ONCOLOGY
- Rational drug repositioning by medical genetics
- (2013) Zhong-Yi Wang et al. NATURE BIOTECHNOLOGY
- Bringing genome-wide association findings into clinical use
- (2013) Teri A. Manolio NATURE REVIEWS GENETICS
- Protocol for effective differentiation of 3T3-L1 cells to adipocytes
- (2012) Katja Zebisch et al. ANALYTICAL BIOCHEMISTRY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Use of genome-wide association studies for drug repositioning
- (2012) Philippe Sanseau et al. NATURE BIOTECHNOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Inferring novel gene-disease associations using Medical Subject Heading Over-representation Profiles
- (2012) Warren A Cheung et al. Genome Medicine
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- Lipoprotein lipase: from gene to obesity
- (2009) Hong Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Bi-Directional SIFT Predicts a Subset of Activating Mutations
- (2009) William Lee et al. PLoS One
- Walking the Interactome for Prioritization of Candidate Disease Genes
- (2008) Sebastian Köhler et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation
- (2008) E. A. Williamson et al. NUCLEIC ACIDS RESEARCH
- Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors
- (2008) Fumihiko Furuya et al. STEROIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now